Hepatitis E: an emerging global disease – from discovery towards control and cure
Grazoprevir plus peginterferon and ribavirin in treatment-naive patients with hepatitis C virus genotype 1 infection: a randomized trial
Understanding decisions made about hepatitis C treatment by couples who inject drugs
Serum miR-122 may serve as a biomarker for response to direct acting antivirals: effect of paritaprevir/R with dasabuvir or ombitasvir on miR-122 in HCV-infected subjects
Costs and outcomes of treating chronic hepatitis C patients in routine care – results from a nationwide multicenter trial
Genetic variation in PTX3 and plasma levels associated with hepatocellular carcinoma in patients with HCV
Reduced healthcare utilization following successful hepatitis C virus treatment in HIV-co-infected patients with mild liver disease
HBx triggers either cellular senescence or cell proliferation depending on cellular phenotype
Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis B in the UK: systematic review and economic evaluation